WINT

Windtree Therapeutics
WINT

Overview Fund Activity
Delisted

WINT was delisted on the 20th of August, 2025.

Back to rankings

25 hedge funds and large institutions have $666K invested in Windtree Therapeutics in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
25
Holders Change
-2
Holders Change %
-7.41%
% of All Funds
0.42%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
9
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$151K
2
Millennium Management
2
Millennium Management
New York
$33K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$243K
4
UBS Group
4
UBS Group
Switzerland
$14K
5
TRCT
5
Tower Research Capital (TRC)
New York
$12K

Top Sellers

1
KC
1
Kepos Capital
New York
$0
2
BlackRock
2
BlackRock
New York
$0
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$35K
4
Northern Trust
4
Northern Trust
Illinois
$21K
5
Federated Hermes
5
Federated Hermes
Pennsylvania
$0
Name Market Value Shares Shares
Change 		Shares
Change %
PA
26
Parallel Advisors
California
$0 11 – –
BBPWM
27
Blue Bell Private Wealth Management
Pennsylvania
$0 5 – –
CFGS
28
Concourse Financial Group Securities
Alabama
– – – –
GI
29
Gradient Investments
Minnesota
$0 23 – –
Wells Fargo
30
Wells Fargo
California
$0 1,274 +12 +1%
1
2